Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT07435038
What this trial is testing

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Betta Pharmaceuticals Co., Ltd. 120
Early research (Phase 1)Ended earlyNCT05397093
What this trial is testing

ITIL-306 in Advanced Solid Tumors

Who this might be right for
Epithelial Ovarian CancerNon-small Cell Lung CancerRenal Cell Carcinoma
Instil Bio 1
Not applicableNot Yet RecruitingNCT07833085
What this trial is testing

CAIX-targeted PET/CT in Solid Tumors

Who this might be right for
Malignant Solid TumorsClear Cell Renal Cell CarcinomaLung Cancer (NSCLC)+1 more
Zhongnan Hospital 100
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Not applicableStudy completedNCT04236102
What this trial is testing

KEBI-Cyto Study - Use of the Biocartis Idylla

Who this might be right for
Pancreatic AdenocarcinomaLung Cancer
Royal Cornwall Hospitals Trust 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04929041
What this trial is testing

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Non-Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 427
Not applicableActive Not RecruitingNCT01345851
What this trial is testing

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+6 more
Jonsson Comprehensive Cancer Center 29
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)WithdrawnNCT03240393
What this trial is testing

Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06099782
What this trial is testing

Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 147
Early research (Phase 1)Not Yet RecruitingNCT07675876
What this trial is testing

Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerLung Adenocarcinoma
Carcinex Inc 10
Early research (Phase 1)Active Not RecruitingNCT02988960
What this trial is testing

ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 163
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Post-approval studies (Phase 4)UnknownNCT04401059
What this trial is testing

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study

Who this might be right for
CarcinomaNon-Small-Cell Lung CancerAdenocarcinoma
Tian Xie 744
Testing effectiveness (Phase 2)Study completedNCT03267316
What this trial is testing

A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors

Who this might be right for
Non Small Cell Lung CancerPancreatic Ductal AdenocarcinomaTriple Negative Breast Cancer+1 more
Cantargia AB 167
Testing effectiveness (Phase 2)Looking for participantsNCT05985655
What this trial is testing

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Next Page